The Use of a Drug Marker in a Clinical Trial
- 1 May 1971
- journal article
- clinical trial
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 16 (5) , 259-260
- https://doi.org/10.1177/003693307101600505
Abstract
A search was made for an ideal drug marker to use in a long-term clinical trial. Sodium fluorescein (4 mg.) was shown to impart urine fluorescence which could be easily and specifically detected. The incorporation of this substance as a marker in the chlorpropamide versus placebo trial for sub-clinical diabetes mellitus is described.Keywords
This publication has 2 references indexed in Scilit:
- A Method to Evaluate Whether Patients Take Prescribed MedicationClinical Pediatrics, 1966
- Riboflavin Marker in Drug ProductsJournal of Pharmaceutical Sciences, 1962